Clustered schedules in allergen-specific immunotherapy

Allergologia et Immunopathologia

Volumn 30, Issue 5, 2002, Pages 283-291

  Parmiani, Silvano ^a,e   Fernandez Tavora L ^b   Moreno, C ^c   Guardia, P ^d   Rico, P ^a  

^a Alk Abellò   (Spain)

^b Ambulatorio Virgen de la Cinta   (Spain)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^e ALK Abello SpA   (Italy)

Author keywords

Aqueous allergenic extracts; Cluster schedule; Depot allergenic extracts; Rush schedule

Indexed keywords

ALLERGEN;

ARTICLE; ASTHMA; BIRCH; CLINICAL FEATURE; CONJUNCTIVITIS; DRUG DELIVERY SYSTEM; EPITHELIUM; GRASS; HUMAN; HYMENOPTERA; IMMUNOTHERAPY; MITE; MOULD; PREMEDICATION; RAGWEED; RHINITIS; SIDE EFFECT;

EID: 0036756662     PISSN: 03010546     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0546(02)79138-6     Document Type: Review

References (33)

1. WHO Position Paper. Allergen Immunotherapy: Therapeutic vaccines for allergic diseases. Allergy 1998;53(Suppl. 44): 1-42.
2. Van Bever HP, Stevens WJ. Suppression of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus). Clin Exp Allergy 1989;399-404.
3. Garcia Ortega P, Merelo A, Marrugat J, Richart C. Decrease of skin and bronchial sensitization following short-intensive scheduled immunotherapy in mite-allergic asthma. CHEST 1993;103:183-7.
4. Pichler CE, Marquardsen A, Sparholt S, Lowenste n H, et al. Specific immunotherapy with Dermatophagoides pteronyssinus results in decreased bronchial reactivity. Allergy 1997; 52:274-83.
5. Tabar A, Muro MD, Garcìa BE, Alvarez MJ, et al. Dermatophagoides pteronyssinus cluster immunotherapy. A controlled trial of safety and clinical efficacy. J Invest Allergol Clin Immunol 1999;9(3): 155-64.
6. Van Metre TE, Adkinson NF, Amodio FJ, Kagey-Sobotka A, et al. A comparison of immunotherapy schedules for injection treatment of ragweed pollen hay fever. J Allergy Clin Immunol 1982;69:181-93.
7. Norman PS, Lichtenstein LM, Kagey-Sobotka A, Marsh DG. Controlled evaluation of allergoid in the immunotherapy of ragweed hay fever. J Allergy Clin Immunol 1982;70:248-60.
8. Stevens WJ, Verhelst JA, Van den Bogaert W, Bridts CH. Clinical and biological evaluation of semi-rush and ordinary immunotherapy schemes in type I allergic respiratory diseases. Allergy 1985;40:447-52.
9. Bousquet J, Maasch H, Martinot B, Hejjaoui A, et al. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy. J Allergy Clin Immunol 1988;82:439-46.
10. Bousquet J, Maasch HJ, Hejjaoui A, Skassa-Brociek W, Wahl R, Dhivert H, Michel FB. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II . Efficacy and safety of unfractionated and high-molecular-weight preparations in rhinoconjunctivitis and asthma. J Allergy Clin Immunol 1989;84:546-56.
11. Fernández-Tavora L, Garcia D. Inmunoterapia cluster con extractos de pólenes: estudio de tolerancia, cambios inmunológicos y eficacia clínica. Rev Esp Alergol Clin Inmunol 1991;6 (1):68-74.
12. Walker S, Pajno GB, Torres Lima M, Wilson DR, et al. Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial. J Allergy Clin Immunol 2001;107: 87-93.
13. Nielsen L, Johnsen CR, Mosbech H, oulsen LK, et al. Antihistamine premedication in specific immunotherapy: a double-blind, placebo-controlled study. J Allergy Clin Immunol 1996;87:1207-13.
14. Dreborg S, Agrell B, Foucard T, Kjellman M, et al. A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. I. Clinical results. Allergy 1986;41:131-40.
15. Malling HJ, Dreborg S, Weeke B. Diagnosis and immunotherapy of Mould Allergy. V. Clinical efficacy and side effects of immunotherapy with Cladosporium herbarum. Allergy 1986; 41:507-19.
16. Bucur J, Dreborg S, Einarsson I, Ljungstedt I, et al. Immunotherapy with dog-sensitive and cat-sensitive asthmatics. Ann Allergy 1989;62:355-61.
17. Haugaard L, Dahl R. Immunotherapy in patients allergic to cat and dog dander. I. Clinical results. Allergy 1992;47:249-54.
18. Hunt KJ, Valentine MD, Sobotka AK, Benton AW, Amodio FJ, Lichtenstein LM. A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med 1978;299(4);157-9.
19. Golden DB, Valentine MD, Kagey-Sobotka A, Lichtenstein LM. Regimens of Hymenoptera venom immunotherapy. Ann Intern Med 1980;92(5):620-4.
20. Müller U, Lanner A, Schmid B, Boschof M, et al. A double-blind study on immunotherapy with chemically modified honey bee venom: monomethoxy polyethylene glycol-coupled versus crude honey bee venom. Int Arch Allergy Appl Immunol 1985; 77:201-9.
21. Malling HJ, Djurup R, Sondergaard I, Weeke B. Clustered immunotherapy with yellow jacket venom. Allergy 1985;40:373-83.
22. Ewan PW, Deighton J, Wilson AB, Lachmann PJ. Venom-specific IgG antibodies in bee and wasp allergy: lack of correlation with protection from stings. Clin Exp Allergy 1993;23:647-60.
23. Vidal C, Fernàndez-Tavora L, Moreno C, Guardia P. Inmunoterapia cluster con un extracto depot de Dermatophagoides pteronyssinus: estudio prospectivo de tolerancia. Rev Esp Alergol Inmunol Clin 1997;12(6):351-5.
24. Fernàndez-Tavora L, Garcìa D. Aqueous extracts and cluster schedule: a good approach for immunotherapy build-up phase. Allergy 1995;50(26):P-0592.
25. Moreno C, Fernàndez-Tavora L, Vidal C, Justicia JL, Guerra F. Estudio prospectivo de seguridad de una pauta agrupada con extracts acuosos de polenes. Alergol Inmunol Clin 2001;16: 95-101.
26. Mellerup MT, Hahn GW, Poulsen LK, Mailing HJ, Safety of allergen specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment. Clin Exp Allergy 2000;30:1423-9.
27. Winther L, Malling HJ, Mosbech H. Allergen-specific immunotherapy in birch- and grass-pollen allergic rhinitis. II. Side effects. Allergy 2000;55:827:35.
28. Moreno C, Fernàndez-Tavora L, Justicia JL, Cabeza N, Vidal C. Bùsqueda de una pauta idònea para iniciaciòn de inmunoterapia con un extracto de Alternaria tenuis. Alergol Inmunol Clin 2001;16:133-7.
29. Tarhini H, Knani J, Michel FB, Bousquet J. Safety of venom immunotherapy administered by a cluster schedule. J Allergy Clin Immunol 1992;89(6):1198-9.
30. Moreno C, Guerra F. Inmunoterapia con veneno de hymenopteros. Seguridad de una pauta agrupada. Alergol Inmunol Clin 1999;14(5):315-21.
31. Quercia O, Rafanelli S, Puccinelli P, Stefanini GF. The safety of cluster immunotherapy with aluminium hydroxide-adsorbed honey bee venom extract. J Invest Allergol Clin Immunol 2001;11(1):27-33.
32. Malling HJ, Weeke B. EAACI Immunotherapy position paper. Allergy 1993;48(Suppl 14):9-35
33. Malling HJ. Immunotherapy as an effective tool in allergy treatment. Allergy 1998;53:461-72.